✦ LIBER ✦

Phosphoantigens and aminobisphosphonates: New leads targeting γδ T lymphocytes for cancer immunotherapy

✍ Scribed by Christian Belmant; Donatella Decise; Jean-Jacques Fournié

Book ID: 119226009
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 303 KB
Volume: 3
Category: Article
ISSN: 1740-6773
DOI: 10.1016/j.ddstr.2006.02.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential of human γδ T lymphocytes for

Potential of human γδ T lymphocytes for immunotherapy of cancer

✍ Dieter Kabelitz; Daniela Wesch; Elke Pitters; Margot Zöller 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 92 KB

## Abstract T lymphocytes are classified into 2 subsets based on their T‐cell receptor (TCR) expression. The vast majority of T cells expresses an αβ TCR heterodimer. These αβ T cells recognize antigenic peptides presented by MHC class I (for CD8^+^ T cells) or MHC class II molecules (for CD4^+^ T

Aminobisphosphonate-pretreated dendritic

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

✍ Florian Cabillic; Olivier Toutirais; Vincent Lavoué; Cécile Thomas de La Pintièr 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 452 KB

NK cell-mediated targeting of human canc

NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy

✍ Karl-Johan Malmberg; Yenan T. Bryceson; Mattias Carlsten; Sandra Andersson; Andr 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 423 KB

In vivo manipulation of Vγ9Vδ2 T cells w

In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients

✍ S. Meraviglia; M. Eberl; D. Vermijlen; M. Todaro; S. Buccheri; G. Cicero; C. La 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB